Nanjing King-Friend Biochemical PharmaceuticalLtd's strong f...
Nanjing King-Friend Biochemical PharmaceuticalLtd's strong financials and high ROE hint at future growth potential, despite recent share price drop. Its heavy reinvestment and profit-sharing commitment are positive, but future performance hinges on whether expected earnings growth is priced into the stock.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000002757c137e776f7.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment